June 19, 2014
Press Release No. 1
News about Engineers India Limited
The media had reports that
Engineers India Limited "EIL wins Nigeria oil refinery contract.”
The Exchange, in order to
verify the accuracy or otherwise of the information reported in the media and
to inform the market place so that the interest of the investors is
safeguarded, had written to the company.
Engineers India Limited has
vide its letter inter-alia stated," EIL approached M/s Dangote Group to
offer its services for their forthcoming project. Discussions In this regard
were concluded and the agreement was initiated on 21st November, 2013 for a
lumpsum value of US$ 139 Millions. Subsequently the agreement has been formally
signed on 2nd June, 2014."
Press
Release No. 2
News about Crompton Greaves Limited
The media had reports that
Crompton Greaves Limited "Crompton Greaves puts land parcel up for sale.”
The Exchange, in order to
verify the accuracy or otherwise of the information reported in the media and
to inform the market place so that the interest of the investors is
safeguarded, had written to the company.
Crompton Greaves Limited
has vide its letter inter-alia stated;" The Company is currently not
negotiating any offer for sale of its land at Kanjurmarg."
Press Release No. 3
Market-wide Position Limit
in GMRINFRA, HDIL
The
derivative contracts in the underlying GMRINFRA, HDIL have crossed 95% of the
market-wide position limit on June 19, 2014. It is hereby informed that all
clients/ members shall trade in derivative contracts of GMRINFRA, HDIL by
offsetting their existing positions till the open interest comes down to 80% of
the market wide position limit.
Press Release No. 4
Listing of
Equity Shares of Caplin Point Laboratories Limited
The equity shares of the following company shall be listed and
admitted to dealings on the Exchange w.e.f. June 23, 2014. Trading shall be in
the Normal Market segment – Compulsory Demat (Rolling Settlement) for all
investors.
|
Sr. No. |
Symbol |
Name of the Company |
ISIN Code |
|
1 |
CAPLIPOINT |
Caplin Point Laboratories
Limited |
INE475E01018 |